New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Four novel receptors may link endometrial cancer to PCOS

Four novel receptors may link endometrial cancer to PCOS

by Impact Journals LLCVisual representation of the datasets used in this study. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28513A new researchpapertitled "Transcrip
OB & GYN January 04,2024
Four novel receptors may link endometrial cancer to PCOS

Four novel receptors may link endometrial cancer to PCOS

by Impact Journals LLCVisual representation of the datasets used in this study. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28513A new researchpapertitled "Transcrip
OB & GYN January 04,2024
A four-drug chemotherapy regimen improves survival in stage 4 pancreatic cancer: Phase 3 clinical trial

A four-drug chemotherapy regimen improves survival in stage 4 pancreatic cancer: Phase 3 clinical trial

byUniversity of California, Los AngelesPancreatic cancer cells (blue) growing as a sphere encased in membranes (red). Credit: National Cancer InstituteA four-drug chemotherapy regimen provided l
Oncology January 04,2024
A four-drug chemotherapy regimen improves survival in stage 4 pancreatic cancer: Phase 3 clinical trial

A four-drug chemotherapy regimen improves survival in stage 4 pancreatic cancer: Phase 3 clinical trial

byUniversity of California, Los AngelesPancreatic cancer cells (blue) growing as a sphere encased in membranes (red). Credit: National Cancer InstituteA four-drug chemotherapy regimen provided l
Oncology January 04,2024
Time of death or personal autonomy? Cancer patients prefer knowing functional prognosis over life expectancy

Time of death or personal autonomy? Cancer patients prefer knowing functional prognosis over life expectancy

byUniversity of TsukubaCredit: AI-generated imageProviding prognostic information is a vital component of cancer patient care. However, the specific information cancer patients prefer to receive
Oncology January 04,2024
Time of death or personal autonomy? Cancer patients prefer knowing functional prognosis over life expectancy

Time of death or personal autonomy? Cancer patients prefer knowing functional prognosis over life expectancy

byUniversity of TsukubaCredit: AI-generated imageProviding prognostic information is a vital component of cancer patient care. However, the specific information cancer patients prefer to receive
Oncology January 04,2024
Sleep disturbances are underappreciated in prostate cancer survivorship

Sleep disturbances are underappreciated in prostate cancer survivorship

by Tim Baker, Prostate Cancer Foundation of AustraliaCredit: CC0 Public DomainWe all got the memo that sleep is foundational for good health, right?Yet, it remains easy to overlook the importance of&n
Oncology January 04,2024
Sleep disturbances are underappreciated in prostate cancer survivorship

Sleep disturbances are underappreciated in prostate cancer survivorship

by Tim Baker, Prostate Cancer Foundation of AustraliaCredit: CC0 Public DomainWe all got the memo that sleep is foundational for good health, right?Yet, it remains easy to overlook the importance of&n
Oncology January 04,2024
Something in the water? Researchers studying large number of late-stage breast cancer cases in Florida county

Something in the water? Researchers studying large number of late-stage breast cancer cases in Florida county

by Cindy Krischer GoodmanCredit: Unsplash/CC0 Public DomainBroward County, Florida's rate of advanced breast cancer exceeds the state and national average, and researchers want to learn why.Could
Oncology January 04,2024
Something in the water? Researchers studying large number of late-stage breast cancer cases in Florida county

Something in the water? Researchers studying large number of late-stage breast cancer cases in Florida county

by Cindy Krischer GoodmanCredit: Unsplash/CC0 Public DomainBroward County, Florida's rate of advanced breast cancer exceeds the state and national average, and researchers want to learn why.Could
Oncology January 04,2024
Dual acting drug delivers blood cancer a lethal 'one-two' punch in mice

Dual acting drug delivers blood cancer a lethal 'one-two' punch in mice

byMonash UniversityCredit: Monash UniversityMelbourne researchers have designed a single drug that delivers a lethal "one-two" punch to several types of blood cancer in preclinical stu
Breakthroughs January 04,2024
Dual acting drug delivers blood cancer a lethal 'one-two' punch in mice

Dual acting drug delivers blood cancer a lethal 'one-two' punch in mice

byMonash UniversityCredit: Monash UniversityMelbourne researchers have designed a single drug that delivers a lethal "one-two" punch to several types of blood cancer in preclinical stu
Breakthroughs January 04,2024
Double testing better at identifying bowel cancer

Double testing better at identifying bowel cancer

byUniversity of EdinburghReceiver operating characteristic (ROC) curve analysis for the detection of colorectal cancer between cohorts. Area under the curve 0.85 (95% c.i. 0.80 to 0.90) for the
Oncology January 04,2024
Double testing better at identifying bowel cancer

Double testing better at identifying bowel cancer

byUniversity of EdinburghReceiver operating characteristic (ROC) curve analysis for the detection of colorectal cancer between cohorts. Area under the curve 0.85 (95% c.i. 0.80 to 0.90) for the
Oncology January 04,2024
How bispecific antibodies could bring new hope to patients with lung cancer

How bispecific antibodies could bring new hope to patients with lung cancer

by Cactus CommunicationsMOAs of bsAbs in the treatment of lung cancer. (A) One arm of a bsAb binds to TAA/TSA, and the other to a T-cell surface receptor, and this bridging mechanism redirects cytotox
Breakthroughs January 04,2024
How bispecific antibodies could bring new hope to patients with lung cancer

How bispecific antibodies could bring new hope to patients with lung cancer

by Cactus CommunicationsMOAs of bsAbs in the treatment of lung cancer. (A) One arm of a bsAb binds to TAA/TSA, and the other to a T-cell surface receptor, and this bridging mechanism redirects cytotox
Breakthroughs January 04,2024
Dual-energy CT iodine concentration differentiates lung cancer from pulmonary metastases

Dual-energy CT iodine concentration differentiates lung cancer from pulmonary metastases

byAmerican Roentgen Ray SocietyContrast-enhanced multiphase DECT of chest performed for surgical planning. Axial image from iodine concentration map, reconstructed from equilibrium-phase acquisi
Medical imageology January 04,2024
Dual-energy CT iodine concentration differentiates lung cancer from pulmonary metastases

Dual-energy CT iodine concentration differentiates lung cancer from pulmonary metastases

byAmerican Roentgen Ray SocietyContrast-enhanced multiphase DECT of chest performed for surgical planning. Axial image from iodine concentration map, reconstructed from equilibrium-phase acquisi
Medical imageology January 04,2024
Dual immunotherapy shows promise to treat recurrent or metastatic nasopharyngeal cancer

Dual immunotherapy shows promise to treat recurrent or metastatic nasopharyngeal cancer

by SingHealthDetails on patient response and outcome data.aExtent and depth of response in trial cohort showing best tumor scan (Top) and changes in tumor size over time (Bottom). Not eval
Oncology January 04,2024
Dual immunotherapy shows promise to treat recurrent or metastatic nasopharyngeal cancer

Dual immunotherapy shows promise to treat recurrent or metastatic nasopharyngeal cancer

by SingHealthDetails on patient response and outcome data.aExtent and depth of response in trial cohort showing best tumor scan (Top) and changes in tumor size over time (Bottom). Not eval
Oncology January 04,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com